CD8A and neoplasm: The approach significantly reduced immunosuppressive myeloid-derived suppressor cells (MDSCs) while substantially increasing anti-tumor immune cells, including m DCs, CD8+ T cells, and B cells, turning the “cold” tumor microenvironment “hot”.